The Effect of Carbohydrate Loading 2 Hours Before Gastroscopy on Gastric Residual Volume and Patient's Well-being Score
Carborie
1 other identifier
interventional
78
1 country
1
Brief Summary
This is a single-blind randomized controlled trial with a stratified (diabetes mellitus, non-diabetes mellitus), balanced randomization (1:1), placebo-controlled study regarding the effect of carbohydrate loading 2 hours prior to the outpatient upper endoscopic procedure. All patients who were assigned for outpatient oesophagogastroduodenoscopy (OGDS) were invited to join in this study voluntarily from January 2021 until August 2021. This study was conducted in the Endoscopy Unit, Hospital Universiti Sains Malaysia, Kubang Kerian, Malaysia. The endoscopists that performed this procedure were blinded and there was trained staff who was not involved in the study to assess the well-being score. The study protocol had been approved by the Human Research Ethics Committee of Universiti Sains Malaysia (JEPeM) with the assigned protocol code USM/JEPeM/20080414.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedFirst Submitted
Initial submission to the registry
October 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2021
CompletedFirst Posted
Study publicly available on registry
November 4, 2021
CompletedNovember 12, 2021
November 1, 2021
8 months
October 9, 2021
November 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To compare the gastric residual volume 2 hours after carbohydrate loading (intervention group) and plain water group (control group)
Patients will be randomised into control group and intervention group. Those in intervention group will have to drink clear water containing carbohydrate (carborie) 2 hours prior to gastroscopy. Endoscopist will measure patient's gastric residual volume. Residual gastric fluid will be aspirated into the container, final volume will be measured.
2 hour before OGDS
Secondary Outcomes (1)
To compare the patient's well-being after ingestion of carbohydrate loading (intervention group) and plain water (control group)
2 hours
Other Outcomes (1)
To assess the effect of carbohydrate loading in patient planned for OGDS in HUSM
2 hours prior OGDS
Study Arms (2)
Plain water
PLACEBO COMPARATORGroup A patient will be given 400cc of plain water, 2 hours prior to gastroscopy
Carborie
EXPERIMENTALGroup B patient will be given 400cc of carborie (carbohydrate drink), 2 hours prior to gastroscopy
Interventions
Measure gastric residual volume during upper endoscopic, after given plain water and carborie 2 hours prior upper endoscopy
Eligibility Criteria
You may qualify if:
- Patient 18 years old and above
- Agree to participate
You may not qualify if:
- History of upper gastrointestinal surgery
- Patient with active gastrointestinal bleeding
- Unstable clinical condition
- Mentally disable or who cannot give an informed consent
- Patient on the nasogastric feeding tube
- Pregnant patient
- American Society of Anesthesiologists classification of physical status grade 3 or above
- Insulin dependent Diabetes Mellitus more than 10 years
- Patient who is carbohydrate intolerance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of General Surgery
Kota Bharu, Kelantan, 15200, Malaysia
Related Publications (6)
Qureshi WA, Zuckerman MJ, Adler DG, Davila RE, Egan JV, Gan SI, Lichtenstein DR, Rajan E, Shen B, Fanelli RD, Van Guilder T, Baron TH; Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: modifications in endoscopic practice for the elderly. Gastrointest Endosc. 2006 Apr;63(4):566-9. doi: 10.1016/j.gie.2006.02.001. No abstract available.
PMID: 16564853RESULTDe Silva AP, Amarasiri L, Liyanage MN, Kottachchi D, Dassanayake AS, de Silva HJ. One-hour fast for water and six-hour fast for solids prior to endoscopy provides good endoscopic vision and results in minimum patient discomfort. J Gastroenterol Hepatol. 2009 Jun;24(6):1095-7. doi: 10.1111/j.1440-1746.2009.05782.x. Epub 2009 Feb 12.
PMID: 19220672RESULTSabry R, Hasanin A, Refaat S, Abdel Raouf S, Abdallah AS, Helmy N. Evaluation of gastric residual volume in fasting diabetic patients using gastric ultrasound. Acta Anaesthesiol Scand. 2019 May;63(5):615-619. doi: 10.1111/aas.13315. Epub 2019 Jan 4.
PMID: 30609007RESULTSpada C, McNamara D, Despott EJ, Adler S, Cash BD, Fernandez-Urien I, Ivekovic H, Keuchel M, McAlindon M, Saurin JC, Panter S, Bellisario C, Minozzi S, Senore C, Bennett C, Bretthauer M, Dinis-Ribeiro M, Domagk D, Hassan C, Kaminski MF, Rees CJ, Valori R, Bisschops R, Rutter MD. Performance measures for small-bowel endoscopy: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. United European Gastroenterol J. 2019 Jun;7(5):614-641. doi: 10.1177/2050640619850365. Epub 2019 May 15.
PMID: 31210941RESULTAmerican Society of Anesthesiologists Committee. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology. 2011 Mar;114(3):495-511. doi: 10.1097/ALN.0b013e3181fcbfd9. No abstract available.
PMID: 21307770RESULTZulkifli MF, Md Hashim MN, Zahari Z, Wong MP, Syed Abd Aziz SH, Yahya MM, Wan Zain WZ, Zakaria AD, Ramely R, Jien Yen S, Othman MF. The effect of pre-endoscopy maltodextrin beverage on gastric residual volume and patient's well-being: a randomised controlled trial. Sci Rep. 2023 Nov 16;13(1):20078. doi: 10.1038/s41598-023-47357-5.
PMID: 37973795DERIVED
Study Officials
- STUDY DIRECTOR
Nizam Hashim, Master
HUSM, Kubang Kerian, Malaysia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Mohd Firdaus bin Zulkifli
Study Record Dates
First Submitted
October 9, 2021
First Posted
November 4, 2021
Study Start
January 1, 2021
Primary Completion
August 31, 2021
Study Completion
October 20, 2021
Last Updated
November 12, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share